Trademark: 97436707
Status Date
Tuesday, August 8, 2023
Registration Number
7134753
Registration Date
Tuesday, August 8, 2023
Filing Date
Tuesday, May 31, 2022
Published for Opposition
Tuesday, October 4, 2022
5 Biotechnological platform technology, namely, cell lines for preparation of biological vectors, and recombinant viruses for gene delivery, that includes recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific production of biologics with therapeutic effect in gene therapy, including gene therapy delivery of antibody biologics, enzymes and RNA interference (RNAi)
Aug 8, 2023
Notice Of Registration Confirmation Emailed
Aug 8, 2023
Registered-Principal Register
Jul 6, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Jul 5, 2023
Allowed Principal Register - Sou Accepted
Jun 20, 2023
Statement Of Use Processing Complete
May 24, 2023
Use Amendment Filed
Jun 17, 2023
Teas Change Of Correspondence Received
Jun 17, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 17, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 17, 2023
Teas Change Of Correspondence Received
Jun 17, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 17, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 16, 2023
Case Assigned To Intent To Use Paralegal
May 24, 2023
Teas Statement Of Use Received
Nov 29, 2022
Noa E-Mailed - Sou Required From Applicant
Oct 4, 2022
Official Gazette Publication Confirmation E-Mailed
Oct 4, 2022
Published For Opposition
Sep 14, 2022
Notification Of Notice Of Publication E-Mailed
Sep 1, 2022
Approved For Pub - Principal Register
Aug 25, 2022
Assigned To Examiner
Jun 8, 2022
New Application Office Supplied Data Entered
Jun 3, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
